16:30 EDT First Wave BioPharma files to sell 3.45M shares of common stock for holders
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on FWBI:
- First Wave BioPharma to Attend the 36th National Cystic Fibrosis Education Conference (July 28-30)
- First Wave BioPharma Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $2.4 Million Gross Proceeds Priced At-the-Market
- FWBI Soars 130% on Reaching Enrollment in Phase 2 Cystic Fibrosis Trial
- First Wave BioPharma reaches enrollment target for Phase 2 SPAN trial
- First Wave BioPharma Reaches Enrollment Target for Phase 2 SPAN Adrulipase Clinical Trial in Cystic Fibrosis